Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
489
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ardelyx Inc market cap is $776.74M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ardelyx Inc 52 week high is $8.40 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ardelyx Inc 52 week low is $2.80 as of November 17, 2026.
Ardelyx Inc stock price today is $3.07.
Ardelyx Inc stock price yesterday was $3.09.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ardelyx Inc's P/E ratio is -13.64.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ardelyx Inc P/B ratio is 4.6979.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ardelyx Inc 50-day moving average is $3.26.